Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: PANIC ATTACK; DIZZINESS; HEADACHE; VERY FATIGUE; LOSS OF BALANCE; CONFUSION; This spontaneous report received from a consumer concerned a 60 year old male. The patient''s height, and weight were not reported. The patient''s concurrent conditions included hypertension, non alcoholic, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 18052029 expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On FEB-2021, Laboratory data included: PCR (NR: not provided) Negative. On 12-APR-2021, the subject experienced loss of balance. On 12-APR-2021, the subject experienced confusion. On 12-APR-2021, the subject experienced dizziness. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced very fatigue. On 15-APR-2021, the subject experienced panic attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from panic attack on 16-APR-2021, and had not recovered from loss of balance, headache, confusion, very fatigue, and dizziness. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166